Bg pattern

GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

GalliaPharm 1,11GBq Radionuclide Generator

Gallium (68Ga) chloride solution

Read all of this leaflet carefully before you receive this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your nuclear medicine specialist who will be supervising the procedure.
  • If you experience any side effects, consult your nuclear medicine specialist, even if they are not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is GalliaPharm and what is it used for
  2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with GalliaPharm
  3. How to use the gallium (68Ga) chloride solution obtained with GalliaPharm
  4. Possible side effects
  5. Storage of GalliaPharm
  6. Package Contents and Further Information

1. What is GalliaPharm and what is it used for

GalliaPharm is a germanium (68Ge)/gallium (68Ga) radionuclide generator, a device used to obtain a gallium (68Ga) chloride solution. The gallium (68Ga) chloride is a substance whose handling is the responsibility of specialized physicians (nuclear medicine specialists) and pharmacists with the necessary training to work with radioactive materials. The gallium (68Ga) chloride is not intended for direct use in patients, but is used for radiolabeling, a technique in which a substance is labeled (radiolabeled) with a radioactive compound, in this case, 68Ga.

Only medicines that have been specifically developed and approved for radiolabeling with 68Ga are subjected to the radiolabeling procedure with gallium (68Ga) chloride. These radiolabeled medicines can recognize and bind to specific types of body cells and carry the radioactive 68Ga to these body cells. The small amount of radioactivity present in the radiolabeled medicine can be detected from outside the body using special cameras. This can help your doctor with diagnosis. For more information, see the package leaflet of the medicine to be radiolabeled with gallium (68Ga) chloride.

Your nuclear medicine specialist will explain the type of examination to be performed in more detail.

The use of a medicine radiolabeled with 68Ga involves receiving a small amount of radioactivity. Your doctor and nuclear medicine specialist have considered that the clinical benefit you will receive from the procedure with the medicine radiolabeled with 68Ga outweighs the risk of radiation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using the gallium (68Ga) chloride solution obtained with GalliaPharm

The gallium (68Ga) chloride solution obtained with GalliaPharm must not be administered

  • if you are allergic to gallium (68Ga) chloride or to any of the other components of this medicine (listed in section 6).

If you are using a medicine radiolabeled with 68Ga, you should read the information on contraindications included in the package leaflet of the medicine to be radiolabeled.

Warnings and Precautions

For information on special warnings and precautions for the use of medicines radiolabeled with 68Ga, see the package leaflet of the medicine to be radiolabeled.

Children and Adolescents

Tell your nuclear medicine specialist if you or your child are under 18 years old.

Other Medicines and the Gallium (68Ga) Chloride Solution

Tell your nuclear medicine specialist if you are taking, have recently taken, or might take any other medicines, as some medicines may interfere with the interpretation of images by your doctor.

It is not known if the gallium (68Ga) chloride solution can interact with other medicines, as no specific studies have been conducted. You will not receive an injection of gallium (68Ga) chloride, but a medicine that has been combined (radiolabeled) with a gallium (68Ga) chloride solution.

For information on other medicines in combination with the use of medicines radiolabeled with 68Ga, see the package leaflet of the radiolabeled medicine.

Pregnancy, Breast-feeding, and Fertility

If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your nuclear medicine specialist before you are given medicines radiolabeled with 68Ga.

If there is any possibility that you may be pregnant, if you have a delayed period, or if you are breast-feeding, inform your nuclear medicine specialist before administration of medicines radiolabeled with 68Ga.

In case of doubt, it is important that you consult your nuclear medicine specialist who will be supervising the procedure.

If you are pregnant

Your nuclear medicine specialist will only administer this radiolabeled medicine with 68Ga during pregnancy if the expected benefit outweighs the risk.

If you are breast-feeding

You will be asked to stop breast-feeding. Ask your nuclear medicine specialist when you can restart breast-feeding.

Driving and Using Machines

Effects on the ability to drive and use machines may occur due to the use of medicines radiolabeled with 68Ga. Read the package leaflets of those medicines carefully.

3. How to use the gallium (68Ga) chloride solution obtained with GalliaPharm

The use, handling, and disposal of radiopharmaceuticals are subject to very strict rules. GalliaPharm will only be used in special controlled areas. The production of the gallium (68Ga) chloride solution, as well as the radiolabeling of a specific carrier medicine and the administration of a medicine radiolabeled with 68Ga, will be the exclusive responsibility of properly trained and qualified personnel to use it safely. These personnel will take special care in the safe use of this medicine and will inform you of their actions.

The nuclear medicine specialist supervising the procedure will decide the amount of radiolabeled medicine with 68Ga to be used in your case. This will be the minimum amount necessary to obtain the desired information.

Administration of the Gallium (68Ga) Chloride Solution and Performance of the Procedure

You will not be administered the gallium (68Ga) chloride solution, but another medicine that has been combined (radiolabeled) with a gallium (68Ga) chloride solution.

Duration of the Procedure

Your nuclear medicine specialist will inform you about the usual duration of the procedure with the medicine radiolabeled with 68Ga. For more information, see the package leaflet of the radiolabeled medicine.

After Administration of the Medicine Radiolabeled with Gallium (68Ga) Chloride Solution

Your nuclear medicine specialist will inform you if you need to take special precautions after you have been administered the medicine radiolabeled with 68Ga. Consult your nuclear medicine specialist if you have any doubts.

If You Have Been Administered More Medicine Radiolabeled with Gallium (68Ga) Chloride Solution Than You Should, or If You Have Received a Direct Injection of Gallium (68Ga) Chloride Solution Accidentally

It is unlikely that an overdose or accidental direct injection of a gallium (68Ga) chloride solution will occur, because you will only receive the medicine radiolabeled with 68Ga under the precise control of the nuclear medicine specialist supervising the procedure. Nevertheless, in case of overdose or accidental direct injection, you will receive the necessary attention.

If you have any further questions on the use of this medicine, ask your nuclear medicine specialist who is supervising the procedure.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Side Effects

Like all medicines, the medicine radiolabeled with 68Ga can cause side effects, although not everybody gets them.

After administration of the medicine radiolabeled with 68Ga, you will be administered low amounts of ionizing radiation with minimal risk of cancer and congenital anomalies.

For more information on possible side effects, see the package leaflet of the radiolabeled medicine.

Reporting of Side Effects

If you experience any side effects, consult your nuclear medicine specialist, even if they are not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of GalliaPharm

You will not need to store this medicine. This medicine is stored under the responsibility of the specialist in suitable premises. The storage of radiopharmaceuticals will be carried out in accordance with national regulations on radioactive materials.

This information is intended only for the specialist.

The radionuclide generator must not be used after the expiry date stated on the container after «EXP».

Do not dismantle the box.

The gallium (68Ga) chloride solution obtained with GalliaPharm must be used immediately.

6. Package Contents and Further Information

Composition of GalliaPharm

  • The active substances are germanium (68Ge) and gallium (68Ga) chloride dissolved in sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l. The germanium (68Ge) is irreversibly trapped within the radionuclide generator and decays into its daughter nuclide (68Ga), which is obtained from the generator as gallium (68Ga) chloride.
  • The other components are: Titanium dioxide (matrix)

Sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (eluate solution)

A radionuclide generator is supplied with:

  1. 1 PP container containing the eluate, 250 ml of sterile ultrapure hydrochloric acid at a concentration of 0.1 mol/l (including a separate hanger for PP vials; PP: polypropylene)
  2. 1 ventilated puncture device (ABS: acrylonitrile butadiene styrene/PE: polyethylene)
  3. 2 1/16” male LUER adapters (PEEK)
  4. 2 tubes (60 cm) (PEEK)
  5. 1 tube (40 cm) (PEEK)
  6. 1 tube (20 cm) (PEEK)
  7. 3 1/16” 10-32 Fingertight connectors (PEEK)
  8. 1 1/16” M6 Fingertight connector (PEEK)
  9. 1 key (TPX: polymethylpentene/HDPE: high-density polyethylene)
  10. 1 male LUER union (PP)

Appearance of the Product and Package Contents

You will not receive or handle this medicine.

Marketing Authorisation Holder and Manufacturer

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Str. 10

13125 Berlin

Germany

Date of Last Revision of this Leaflet:

Other Sources of Information

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu.

The package leaflet of this medicine can be found in all languages of the European Union/European Economic Area on the European Medicines Agency website.

--------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

The full summary of product characteristics of GalliaPharm is provided in a separate document in the product packaging, with the aim of providing healthcare professionals with additional scientific and practical information on the administration and use of this radiopharmaceutical.

See the summary of product characteristics or package leaflet.

Online doctors for GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR

Discuss questions about GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (21)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

Camera Book a video appointment
€60
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?
GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?
GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR is manufactured by Eckert & Ziegler Radiopharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GALLIAPHARM 1.11 GBq RADIONUCLIDE GENERATOR?
Other medicines with the same active substance () include GALLIAPHARM 0.74 - 1.85 GBq RADIONUCLIDE GENERATOR, NORCOLESTEROL IODINATED (131 I) CIS BIO INTERNATIONAL 7.5-15 MBq/ml INJECTABLE SOLUTION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media